Las Vegas, NV -- (SBWIRE) -- 10/14/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Delek US Holdings, Inc. (NYSE:DK), Apollo Investment Corp. (NASDAQ:AINV), Key Energy Services, Inc. (NYSE:KEG), Infinity Pharmaceuticals Inc. (NASDAQ:INFI)
Delek US Holdings, Inc. (NYSE:DK) managed to keep its gain at 8.65% on above-normal volume of 2.02M shares. The stock settled at $23.99 after floating in a range of $22.09 to $24.20. Its latest price has reached market capitalization of $1.44 billion. Its 52-week range has been $19.83 to $41.47. Delek US Holdings, Inc. (Delek) is an integrated energy business focused on petroleum refining, the wholesale distribution of refined products and convenience store retailing.
For How Long DK will fight for Profitability? Read This Trend Analysis report
Apollo Investment Corp. (NASDAQ:AINV) traded up on a volume of 2.02 million, higher than its standard daily volume. Shares have gained 1.58% to $3.38. Over the last twelve months, the stock has gained 6.89% and faced a worst price of $7.21. Apollo Investment Corporation (Apollo Investment) is a closed-end, non-diversified management investment company that has elected to be treated as a business development company.
For How Long AINV’s Gloss will Attract Investors? Find out via this report
Key Energy Services, Inc. (NYSE:KEG) settled 1.11% higher at $7.30 on below -normal volume of 2M shares during the last trading day. The stock has its 12-month high at $9.55 and 52-week low price was $5.61. It traded in a range of $7.10 to $7.35 during the last trading day. Key Energy Services, Inc. operates as an onshore rig-based well servicing contractor in the United States and internationally.
Why Should Investors Buy KEG After the Recent Fall? Just Go Here and Find Out
In the last trading session, Infinity Pharmaceuticals Inc. (NASDAQ:INFI) was down on high volume, trading at a volume of 2M versus its average daily volume of 765,418.00 shares. At $13.82, the stock has attained market capitalization of 663.13 million. Infinity Pharmaceuticals, Inc., a drug discovery and development company, focuses on discovering, developing, and delivering medicines to patients for diseases with significant unmet need.
Why Should Investors Buy INFI After the Recent Fall? Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)